1
Total investments
0
Early stage
1
Mid stage
0
Late stage
5y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor - Good Rebels 💛🌱
May 2021
Our mission is to build a net-positive food system by accelerating the protein transition with the ambition of not just being an alternative to current problems but successors by creating value chains that integrate what matters and empowering people to be part of this change.
Experience · 5 entries
All (5)
Investments (1)
Founder (2)
2023
Master Data Product Owner
Apr 2023
Pernod Ricard is a convivial, responsible and successful global wine and spirits group and the #1 premium spirits organisation in the world. The Group represents 240 premium brands available in more than 160 countries. We are 18,500 exceptionally talented people worldwide with our own salesforce in 73 countries.
Our portfolio is one of the most comprehensive in the market with every major category of wine and spirits, providing Pernod Ricard with a unique competitive advantage. To keep growing our business, transforming our industry and making a positive impact on the world, we believe in the power of human connection. Creating ‘convivialité’ is our business and our raison d’être.
As ‘créateurs de convivialité’, our purpose is to turn every social interaction into a genuine, friendly and responsible experience of sharing. We believe there can be no convivialité with excess and strive to be sustainable and responsible at every step, from grain to glass.
You must be of legal drinking age to follow and only share with others of age. Enjoy our brands responsibly.
UGC policy: https://bit.ly/41XEYbx
2021
Product Owner
Sep 2021
Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance model, it can fully serve its vocation with a long-term vision: being committed to therapeutic progress to serve patient needs. The 21,900 employees of the Group are committed to this shared vocation, source of inspiration every day.
As a world leader in cardiology, Serviers ambition is to become a focused and innovative player in oncology by targeting hard-to-treat cancers. That is why the Group allocates over 70% of its R&D budget to developing targeted and innovative therapies in oncology.
Neuroscience and immuno-inflammatory diseases are the future growth drivers. In these areas, Servier is focused on a limited number of diseases in which accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine.
To promote access to quality care for all at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, relying on strong brands in France, Eastern Europe, Brazil and Nigeria.
In all these areas, the Group includes the patient voice at each stage of the life cycle of a medicine.
Headquartered in France, Servier relies on a strong geographical footprint in over 150 countries and achieved a revenue of €5.3 billion in 2023.
--
To report a suspected adverse event with a Servier drug, please visit servier.com
Associate
Aug 2021
Entrepreneurship in the service of the climate emergency!
We identify, fund, and launch 100 companies designed and structured from start to finish to combat greenhouse gases.
Our mission:
> identify high-impact innovations;
> recruit experienced entrepreneurs to transform these innovations into companies with solid business models;
> inject financial resources to maximize and accelerate deployment.
All innovations are made available as open source.
Every euro raised is used to combat climate change.
Any individual or organization can join the effort starting at €1 on our website (in just a few minutes) and take concrete action, on a global scale, against climate change.
Everything is detailed (and you can contact us) at team-planet.com
Investor - Good Rebels 💛🌱
May 2021
Our mission is to build a net-positive food system by accelerating the protein transition with the ambition of not just being an alternative to current problems but successors by creating value chains that integrate what matters and empowering people to be part of this change.
MDM Business Analyst Consultant - Business Partner Repository
Jan 2021
No.1 Beauty Group Worldwide.
No.1 most innovative company in Europe (Fortunes ranking).
We are 90K employees across 150 countries on five continents, united by our shared purpose: creating the beauty that moves the world.
Our 37 international brands are divided into four unique Divisions: Luxe, Consumer Products, Dermatological Beauty, and Professional Products. This diverse portfolio includes brands like Kiehl’s, Lancôme, Giorgio Armani Beauty, Yves Saint Laurent Beauté, Ralph Lauren, Aesop, Maybelline New York, Essie, Kérastase, IT Cosmetics, Prada Beauty, Biotherm, Shu Uemura, Viktor&Rolf, Maison Margiela, Urban Decay, Redken, Vichy, La Roche-Posay, Diesel, Garnier, L’Oréal Paris, and more.
For more than a century, L’Oréal has devoted itself solely to one business: beauty. We want to bring beauty to all people. Our goal is to win over another one billion consumers around the world by innovating and creating cosmetic and skincare products that meet the infinite diversity of their beauty needs and desires.
That’s about us… now what about you? You are driven and up for a challenge! You’re passionate about putting your best foot forward, but you’re not afraid to fail either. You love to learn, grow and make an impact on the world. You can be an intern, or at a senior level position, we’re always looking for new people to join our teams.
If you are ready to take charge of your career and join us, you’re one click away: https://careers.loreal.com/en_US/content
Interested about our quest to the next billion consumers, follow us here to get the insider scoop on our business, culture, and tips on how to join us to shape the future of beauty.
Freedom to go beyond, that’s the beauty of L’Oréal.
